[1]方砚 王效浣 郭朝霞.血流介导性血管扩张评价心血管病患者肱动脉内皮功能的研究进展[J].心血管病学进展,2019,(5):793-796.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.032]
 FANG Yan,WANG Xiaohuan,GUO Zhaoxia.Flow- mediated Vasodilation Evaluation of Brachial Artery Endothelial Function in Patients with Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):793-796.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.032]
点击复制

血流介导性血管扩张评价心血管病患者肱动脉内皮功能的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年5期
页码:
793-796
栏目:
综述
出版日期:
2019-08-25

文章信息/Info

Title:
Flow- mediated Vasodilation Evaluation of Brachial Artery Endothelial Function in Patients with Cardiovascular Disease
作者:
方砚 王效浣 郭朝霞
(甘肃省人民医院心内科,甘肃 兰州 730000)
Author(s):
FANG YanWANG XiaohuanGUO Zhaoxia
(Department of Cardiology,Gansu Provincial People’s Hospital,Lanzhou 730000,Gansu,China)
关键词:
血流介导的内皮依赖性血管舒张反应内皮功能心力衰竭冠心病
Keywords:
Flow-mediated vasodilation Endothelial function Heart failure Coronary heart disease
DOI:
10.16806/j.cnki.issn.1004-3934.2019.05.032
摘要:
近年来开展的利用血流介导的内皮依赖性血管舒张反应检测肱动脉内皮功能的方法,已广泛被用来作为评价心血管疾病血管内皮功能的无创指标。现将肱动脉舒张反应在心力衰竭的发病机制、冠心病的诊治以及预后评估等方面应用的国内外最新进展进行综述。
Abstract:
Flow-mediated vasodilation evaluation of brachial artery endothelial function in recent years, has become the most widely used non-invasive means, and it has been an indicator used to assess vascular function. This article introduces the flow-mediated vasodilation evaluation of brachial artery endothelial function, and reviewed its advancement on the application of pathogenesis of heart failure.The protective effect of cardiac rehabilitation on endothelial function in patients with heart failure,diagnosis and treatment of coronary heart disease and other cardiovascular fields.

参考文献/References:


[1]Matsui S,Kajikawa M,Maruhashi T,et al. New assessment of endothelial function measured by short time flow-mediated vasodilation:comparison with conventional flow-mediated vasodilation measurement [J]. Int J Cardiol,2018,265:24-29.

[2] Corretti MC,Anderson TJ,Benjamin EJ,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery:a report of the International Brachial Artery Reactivity Task Force [J]. J Am Coll Cardiol,2002,39(2):257-265.

[3] Kishimoto S,Kajikawa M,Maruhashi T,et al. Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction[J]. Int J Cardiol,2017,231:181-187.

[4] Franssen C,Chen S,Unger A,et al. Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction[J]. JACC Heart Fail,2016,4(4):312-324.

[5] Russomanno G,Corbi G,Manzo V,et al. The anti-ageing molecule sirt1 mediates beneficial effects of cardiac rehabilitation[J]. Immun Ageing,2017,14:7.

[6] Kato M,Masuda T,Ogano M,et al. Stretching exercises improve vascular endothelial dysfunction through attenuation of oxidative stress in chronic heart failure patients with an implantable cardioverter defibrillator[J]. J Cardiopulm Rehabil Prev,2017,37(2):130-138.

[7] Guiraud T,Labrunée M,Besnier F,et al. Whole-body strength training with Huber Motion Lab and traditional strength training in cardiac rehabilitation:a randomized controlled study[J]. Ann Phys Rehabil Med,2017,60(1):20-26.

[8] Tanaka S,Sanuki Y,Ozumi K,et al. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation:impact of endothelial function[J]. Heart Vessels,2018,33(8):886-892.

[9] Pearson MJ,Smart NA. Aerobic training intensity for improved endothelial function in heart failure patients: a systematic review and meta-analysis[J]. Cardiol Res Pract,2017,2017:2450202.

[10] Tanaka S,Sanuki Y,Ozumi K,et al. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation:impact of endothelial function[J]. Heart Vessels,2018,33(8):886-892.

[11] Oikonomou E,Siasos G,Zaromitidou M,et al. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients[J]. Atherosclerosis,2015,238(2):159-164.

[12] Kabutoya T,Hoshide S,Kario K.Integrated flow-mediated vasodilation response predicts cardiovascular events in elderly patients with cardiovascular risk factors: the Japan Morning Surge-Home Blood Pressure study[J]. J Am Soc Hypertens,2018,12(5):340-345.

[13] Park KH,Han SJ,Kim HS,et al. Impact of Framingham risk score, flow-mediated dilation, pulse wave velocity, and biomarkers for cardiovascular events in stable angina[J]. J Korean Med Sci,2014,29(10):1391-1397.

[14]Sugamata W,Nakamura T,Uematsu M,et al. Combined assessment of flow-mediated dilation of the brachial artery and brachial-ankle pulse wave velocity improves the prediction of future coronary events in patients with chronic coronary artery disease[J]. J Cardiol,2014,64(3):179-184.

[15]Giulia Careri, MD, Roberto Nerla, et al. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes [J]. Am J Cardiol,2013,111:51-57.

[16]Lanza GA,Scalone G,Barone L,?et al. Platelet reactivity and endothelial function in children of patients with early acute myocardial infarction[J]. Eur Heart J,2011,32:2042-2049.

[17]Kubo M,Miyoshi T,Oe H,et al. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents[J]. BMC Cardiovasc Disord,2015,15:102.

[18]Li Y,Chen F,Zhang X,et al. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention[J]. Int J Clin Exp Pathol,2015,8(6):7350-7357.

[19] Peller M,Ozierański K,Balsam P,et al. Influence of beta-blockers on endothelial function:a meta-analysis of randomized controlled trials[J]. Cardiol J,2015,22(6):708-716.

[20] Radenkovic M,Stojanovic M,Prostran M. Calcium channel blockers in restoration of endothelial function: systematic review and meta-analysis of randomized controlled trials[J]. Curr Med Chem,2018,Jul 13.DOI: 10.2174/0929867325666180713144806 [Epub ahead of print].

[21] Eguchi K,Hoshide S,Kario K. Effects of celiprolol and bisoprolol on blood pressure, vascular stiffness, and baroreflex sensitivity[J]. Am J Hypertens,2015,28(7):858- 867.

[22] Miyamoto M,Kotani K,Taniguchi N. Effect of non-antihypertensive drugs on endothelial function in hypertensive subjects evaluated by flow-mediated vasodilation[J]. Curr Vasc Pharmacol,2015,13(1):121-127.

[23] Oikonomou E,Siasos G,Zaromitidou M,et al. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients[J] . Atherosclerosis,2015,238(2):159-164.

[24] Shinnakasu A,Yamamoto K,Kurano M,et al. The combination therapy of fenofibrate and ezetimibe improved lipid profile and vascular function compared with statins in patients with type 2 diabetes[J]. J Atheroscler Thromb,2017,24(7):735-748.

[25]Boncelj Svetek M,Er?en B,Kanc K,et al. Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan[J]. J Diabetes Complications,2017,31(3):544-550.

[26] Jani? M,Lunder M,Cerkovnik P,et al. Low-dose fluvastatin and valsartan rejuvenate the arterial wall through telomerase activity increase in middle-aged men[J]. Rejuvenation Res,2016,19(2):115-119.

[27] Zhao J,Yan HM,Li Y,et al. Pitavastatin calcium improves endothelial function and delays the progress of atherosclerosis in patients with hypercholesterolemia[J]. J Zhejiang Univ Sci B,2015,16(5):380-387.

[28] Zhang H,Niu H,Yuan X. Trimetazidine combined with berberine on endothelial function of patients with coronary heart disease combined with primary hypertension[J]. Exp Ther Med,2018,16(2):1318-1322.

[29] Sawada T,Tsubata H,Hashimoto N,et al. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia,hyperlipidemia,insulin secretion ability,and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label,single blinded,prospective randomized controlled trial [J]. Cardiovasc Diabetol,2016,15(1):121.

[30] Rocha HNM,Garcia VP,Batista GMS,et al. Disturbed blood flow induces endothelial apoptosis without mobilizing repair mechanisms in hypertension[J]. Life Sci,2018,209:103-110.

[31] Kumar M,Sharma Y,Bahl A. Evaluation of endothelial dysfunction in idiopathic dilated cardiomyopathy patients[J]. J Assoc Physicians India,2018,66(3):26-28.

[32] Malhotra AS, Goel P, Chaudhary A. Serial profile of flow-mediated dilatation in primigravida for prediction of preeclampsia and gestational hypertension[J]. Hypertens Pregnancy,2018,1:1-8.

相似文献/References:

[1]杨再英,王钰.川崎病后无创检查评估血管内皮功能的研究进展[J].心血管病学进展,2019,(6):939.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.025]
 YANG Zaiying,WANG Yu.Non-invasive Assessment of Vascular Endothelial Function after Kawasaki Disease[J].Advances in Cardiovascular Diseases,2019,(5):939.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.025]

备注/Memo

备注/Memo:
基金项目:2018年甘肃省中医药管理局科研课题(GZK-2018-44)
更新日期/Last Update: 2019-12-25